Alopecia Areata (Hair Loss)
Alopecia areata is a dermatologic disorder that can affect both men and women. It is an auto-immune condition and the severity ranges from very mild to total loss of all scalp and body hair.
Trial for patients aged 18+ suffering from alopecia areata persisting for over six months
Participants: Adults 18 years and older
Drug Type: Baricitinib or placebo
Status and Location: Currently Recruiting at Westmead
Fill in your details in the form below to register your interest. Our clinical trials coordinator will be in touch shortly to discuss your eligibility for the trial.
Alternatively, ring us on 02 8279 2739 to speak to our clinical trials team today or Email firstname.lastname@example.org
Trial for treating male and female pattern hair loss (androgenic alopecia)
Participants: Please register your interest for upcoming alopecia trials in the form below.
Drug Type and Administration: Light therapy